{"filings":[{"id":91712,"accession_number":"0001213900-26-052833","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","5.07","7.01","9.01"],"status":"ready","headline":"Herbalife Q1 net sales $1.3B (+7.8% YoY); raises FY2026 constant-currency guidance midpoints","event_type":"earnings","confidence":"high","bullets":["Q1 net sales $1.3B (+7.8% YoY); adjusted EBITDA $175.7M above guidance; diluted EPS $0.57, adjusted $0.64.","FY2026 guidance raised: constant-currency net sales and adjusted EBITDA midpoints increased; capex reaffirmed.","Completed $1.45B senior secured debt refinancing on April 29, reducing net leverage to 2.1x.","Acquired substantially all assets of Bioniq's personalized nutrition business on April 30.","Annual meeting: all 11 director nominees elected; say-on-pay and auditor ratification approved."],"consensus_eps_estimate":null,"consensus_eps_actual":0.57,"consensus_revenue_estimate":null,"consensus_revenue_actual":1317200000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91711,"accession_number":"0001213900-26-051010","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2026-05-01T23:59:59+00:00","items":["1.01","2.03","2.04","8.01","9.01"],"status":"ready","headline":"Herbalife completes $1.45B refinancing, issues $800M 7.75% notes due 2033, redeems 12.25% notes","event_type":"debt","confidence":"high","bullets":["Issued $800M aggregate principal of 7.750% Senior Secured Notes due 2033 (the '2033 Secured Notes').","Amended 2024 credit facility to $225M Term Loan A and $425M revolving credit facility, both due April 2031.","Used net proceeds and cash to repay $365M term loan B and redeem $800M of 12.250% notes due 2029 at 106.125% of principal.","Expects approximately $45 million in annual cash interest savings from the refinancing.","Approximately $200 million was outstanding under the revolving credit facility as of April 29, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91710,"accession_number":"0001213900-26-044204","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2026-04-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Herbalife prices $800M of 7.750% senior secured notes due 2033; proceeds to refinance higher-cost debt","event_type":"debt","confidence":"high","bullets":["$800M aggregate principal at 7.750% fixed, due 2033; priced at 100% of par.","Interest payable semi-annually on May 1 and Nov 1, starting Nov 1, 2026.","Net proceeds to repay existing debt including 12.250% Senior Secured Notes due 2029.","Offering expected to close April 29, 2026, subject to customary conditions.","Notes not registered; offered under Rule 144A and Regulation S."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91709,"accession_number":"0001213900-26-043269","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2026-04-14T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Herbalife Q1 preliminary net sales growth 7.5-8.0% YoY above guidance; announces $800M notes offering to refinance debt","event_type":"other_material","confidence":"high","bullets":["Preliminary Q1 net sales growth 7.5-8.0% YoY (5.0-5.5% constant currency), beating high end of guidance; Adj. EBITDA at or above guidance.","Record quarterly net sales in India drove Asia Pacific outperformance; North America and China declined YoY.","Refinancing plan targets $1,450M secured debt ($425M revolver, $225M Term Loan A, $800M other secured notes).","Company proposes $800M senior secured notes due 2033; net proceeds to repay existing debt including 12.250% notes due 2029.","Conditional redemption of existing $800M 2029 notes at 106.125% of par plus accrued interest, contingent on completion of new financing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101969,"accession_number":"0001213900-26-017966","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2026-02-18T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q4 net sales +6.3% to $1.3B, adj EBITDA $156.1M; Ronaldo invests $7.5M in Pro2col","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $1.3B, +6.3% YoY; constant currency +5.5%; both exceed guidance.","Q4 adj EBITDA $156.1M ($167.7M constant currency); diluted EPS $0.81, adj EPS $0.45.","FY net sales $5.0B (+0.9% YoY), adj EBITDA $657.6M; credit agreement EBITDA $742.0M, leverage 2.8x.","Cristiano Ronaldo invested $7.5M for 10% equity stake in Herbalife's Pro2col Software technology unit."],"consensus_eps_estimate":null,"consensus_eps_actual":2.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":5037500000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118304,"accession_number":"0001213900-25-106671","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q3 net sales $1.3B (+2.7% YoY), adj. EBITDA $163M beats guidance; tightens FY25 ranges","event_type":"earnings","confidence":"high","bullets":["Net sales $1.3B, above guidance midpoint; up 2.7% YoY (3.2% constant currency).","North America returned to growth with +1.0% YoY, first quarterly gain since Q2 '21.","Adjusted EBITDA $163.0M exceeds guidance; Adjusted EPS $0.50; Net income $43.2M.","Repaid $147.3M of 2025 Notes; leverage ratio reduced to 2.8x.","Full-year guidance tightened: net sales and adj. EBITDA ranges narrowed; Q4 guidance provided."],"consensus_eps_estimate":null,"consensus_eps_actual":1.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":3754500000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134751,"accession_number":"0001213900-25-072568","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q2 net sales $1.3B near guidance mid; adjusted EBITDA $173.6M beats; raises 2025 outlook","event_type":"earnings","confidence":"high","bullets":["Net sales of $1.3B down 1.7% YoY (flat constant currency); net income $49.3M, diluted EPS $0.48.","Adjusted EBITDA $173.6M exceeded guidance; Credit Agreement EBITDA $192.4M; leverage ratio 3.0x.","Adjusted net income $60.5M; adjusted diluted EPS $0.59.","Raised full-year net sales and adjusted EBITDA guidance; launched MultiBurn supplement in July.","Unveiled beta version of Pro2col digital platform and healthy lifespan supplement at July event."],"consensus_eps_estimate":null,"consensus_eps_actual":0.97,"consensus_revenue_estimate":null,"consensus_revenue_actual":2480800000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151657,"accession_number":"0001213900-25-054756","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2025-06-16T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Herbalife redeems $50M of 7.875% Senior Notes due 2025 at par on June 30","event_type":"debt","confidence":"high","bullets":["Redeeming $50 million aggregate principal of 7.875% Senior Notes due 2025 at par.","Redemption date is June 30, 2025; price $1,000 per $1K principal plus accrued interest.","Issuers: Herbalife Ltd. and wholly-owned subsidiary HLF Financing, Inc.","Reduction in outstanding debt lowers future interest expense."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151656,"accession_number":"0001213900-25-037675","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q1 net sales $1.2B (down 3.4% YoY), adjusted EBITDA $164.9M beats guidance","event_type":"earnings","confidence":"high","bullets":["Net sales $1.2B at midpoint of guidance; down 3.4% YoY but up 1.4% on constant-currency basis.","Net income $50.4M; adjusted net income $59.9M; diluted EPS $0.49, adjusted diluted EPS $0.59.","Adjusted EBITDA $164.9M exceeds guidance; margin up 260 bps vs Q1 '24; leverage ratio reduced to 3.0x.","Full-year 2025 guidance revised: net sales range narrowed, adjusted EBITDA raised, capex reduced.","Completed acquisitions of Pro2col Health and Pruvit Ventures; formed HBL Link Bioscience with 51% ownership."],"consensus_eps_estimate":null,"consensus_eps_actual":0.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":1221700000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151655,"accession_number":"0001213900-25-035657","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2025-04-25T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Herbalife shareholders elect 11 directors, approve say-on-pay and auditor ratification at 2025 AGM","event_type":"other_material","confidence":"high","bullets":["All 11 board nominees elected with majority votes; Michael O. Johnson received 67.1M for, 1.5M against.","Advisory say-on-pay approved narrowly: 35.3M for, 33.2M against, 323,675 abstentions.","Ratification of PricewaterhouseCoopers as auditor for FY2025 passed with 80.4M for, 2.4M against.","Broker non-votes of 14.2M shares were recorded on director elections and say-on-pay."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170504,"accession_number":"0001213900-25-015314","cik":1180262,"company_name":"HERBALIFE LTD.","ticker":"HLF","form_type":"8-K","filed_at":"2025-02-19T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Herbalife Q4 Adj EBITDA $150M beats guidance; Stephan Gratziani appointed CEO","event_type":"leadership","confidence":"high","bullets":["Q4 net sales $1.2B, down 0.6% YoY but up 2.7% constant currency; at high end of guidance.","Q4 adjusted EBITDA $150.0M, exceeding guidance; margin up 340 bps vs Q4'23.","Full-year adjusted EBITDA $634.8M, above guidance; leverage ratio reduced to 3.2x.","Stephan Gratziani appointed CEO effective May 1, 2025; Michael Johnson becomes Executive Chairman.","Rob Levy named President, Worldwide Markets, succeeding Gratziani."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}